Plasmin triggers a switch-like decrease in thrombospondin-dependent activation of TGF-β1

Biophysical Journal

Volumn 103, Issue 5, 2012, Pages 1060-1068

  Venkatraman, Lakshmi ^a,b   Chia, Ser Mien ^a   Narmada, Balakrishnan Chakrapani ^c   White, Jacob K ^a,f   Bhowmick, Sourav S ^a,b   Forbes Dewey, C ^a,g   So, Peter T ^a,g   Tucker Kellogg, Lisa ^a,e   Yu, Hanry ^a,c,d,e,h  

^a SINGAPORE MIT ALLIANCE   (Singapore)

^b NANYANG TECHNOLOGICAL UNIVERSITY   (Singapore)

^c NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^d NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^e NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^f USA   (United States)

^g Massachusetts Institute of Technology Cambridge   (United States)

^h INSTITUTE OF BIOENGINEERING AND NANOTECHNOLOGY   (Singapore)

Author keywords

[No Author keywords available]

Indexed keywords

PLASMIN; THROMBOSPONDIN 1; TRANSFORMING GROWTH FACTOR BETA1;

ANIMAL; ARTICLE; BIOLOGICAL MODEL; COCULTURE; CYTOLOGY; DOSE RESPONSE; DRUG EFFECT; LIVER CELL; METABOLISM; PROTEIN STABILITY; RAT; STELLATE CELL;

ANIMALS; COCULTURE TECHNIQUES; DOSE-RESPONSE RELATIONSHIP, DRUG; FIBRINOLYSIN; HEPATIC STELLATE CELLS; HEPATOCYTES; MODELS, BIOLOGICAL; PROTEIN STABILITY; RATS; THROMBOSPONDIN 1; TRANSFORMING GROWTH FACTOR BETA1;

RATTUS;

EID: 84865774133     PISSN: 00063495     EISSN: 15420086     Source Type: Journal    
DOI: 10.1016/j.bpj.2012.06.050     Document Type: Article

References (67)

1. T. Kisseleva, and D.A. Brenner Mechanisms of fibrogenesis Exp. Biol. Med. (Maywood) 233 2008 109 122
2. W.B. Reeves, and T.E. Andreoli Transforming growth factor β contributes to progressive diabetic nephropathy Proc. Natl. Acad. Sci. USA 97 2000 7667 7669
3. D. Padua, and J. Massagué Roles of TGFβ in metastasis Cell Res. 19 2009 89 102
4. G.C. Blobe, W.P. Schiemann, and H.F. Lodish Role of transforming growth factor β in human disease N. Engl. J. Med. 342 2000 1350 1358
5. H. Shankaran, and H.S. Wiley Smad signaling dynamics: insights from a parsimonious model Sci. Signal. 1 2008 pe41
6. B. Schmierer, and A.L. Tournier C.S. Hill Mathematical modeling identifies Smad nucleocytoplasmic shuttling as a dynamic signal-interpreting system Proc. Natl. Acad. Sci. USA 105 2008 6608 6613
7. J.P. Annes, J.S. Munger, and D.B. Rifkin Making sense of latent TGFβ activation J. Cell Sci. 116 2003 217 224
8. B. Dabovic, and D.B. Rifkin TGF-β bioavailability: latency, targeting and activation R. Derynck, K. Miyazono, The TGF-β Family 2008 Cold Spring Harbor Laboratory Press Long Island, NY 1114
9. P. Bornstein Thrombospondins as matricellular modulators of cell function J. Clin. Invest. 107 2001 929 934
10. S.E. Crawford, and V. Stellmach N. Bouck Thrombospondin-1 is a major activator of TGF-β1 in vivo Cell 93 1998 1159 1170
11. C. Hugo The thrombospondin 1-TGF-β axis in fibrotic renal disease Nephrol. Dial. Transplant. 18 2003 1241 1245
12. H. Kondou, and S. Mushiake K. Ozono A blocking peptide for transforming growth factor-β1 activation prevents hepatic fibrosis in vivo J. Hepatol. 39 2003 742 748
13. M. Sajid, M. Lele, and G.A. Stouffer Autocrine thrombospondin partially mediates TGF-β1-induced proliferation of vascular smooth muscle cells Am. J. Physiol. Heart Circ. Physiol. 279 2000 H2159 H2165
14. Y. Mimura, and H. Ihn K. Tamaki Constitutive thrombospondin-1 overexpression contributes to autocrine transforming growth factor-β signaling in cultured scleroderma fibroblasts Am. J. Pathol. 166 2005 1451 1463
15. R.M. Lyons, and L.E. Gentry H.L. Moses Mechanism of activation of latent recombinant transforming growth factor β1 by plasmin J. Cell Biol. 110 1990 1361 1367
16. J.F. Bohmfalk, and G.M. Fuller Plaminogen is synthesized by primary cultures of rat hepatocytes Science 209 1980 408 410
17. T.A. Drixler, and J.M. Vogten I.H. Borel Rinkes Plasminogen mediates liver regeneration and angiogenesis after experimental partial hepatectomy Br. J. Surg. 90 2003 1384 1390
18. G.K. Michalopoulos Liver regeneration J. Cell. Physiol. 213 2007 286 300
19. H.R. Lijnen Pleiotropic functions of plasminogen activator inhibitor-1 J. Thromb. Haemost. 3 2005 35 45
20. A. Martínez-Rizo, and M. Bueno-Topete J. Armendáriz-Borunda Plasmin plays a key role in the regulation of profibrogenic molecules in hepatic stellate cells Liver Int. 30 2010 298 310
21. Y. Huang, and M. Haraguchi N.A. Noble A mutant, noninhibitory plasminogen activator inhibitor type 1 decreases matrix accumulation in experimental glomerulonephritis J. Clin. Invest. 112 2003 379 388
22. A. Bonnefoy, and C. Legrand Proteolysis of subendothelial adhesive glycoproteins (fibronectin, thrombospondin, and von Willebrand factor) by plasmin, leukocyte cathepsin G, and elastase Thromb. Res. 98 2000 323 332
23. P.J. Hogg, J. Stenflo, and D.F. Mosher Thrombospondin is a slow tight-binding inhibitor of plasmin Biochemistry 31 1992 265 269
24. J.M. Vilar, R. Jansen, and C. Sander Signal processing in the TGF-β superfamily ligand-receptor network PLOS Comput. Biol. 2 2006 e3
25. B.B. Aldridge, and J.M. Burke P.K. Sorger Physicochemical modelling of cell signalling pathways Nat. Cell Biol. 8 2006 1195 1203
26. U.S. Bhalla, and R. Iyengar Emergent properties of networks of biological signaling pathways Science 283 1999 381 387
27. G. Yao, and T.J. Lee L. You A bistable Rb-E2F switch underlies the restriction point Nat. Cell Biol. 10 2008 476 482
28. B. Novak, and J.J. Tyson A. Csikasz-Nagy Irreversible cell-cycle transitions are due to systems-level feedback Nat. Cell Biol. 9 2007 724 728
29. L. Venkatraman, and H. Li L. Tucker-Kellogg Steady states and dynamics of urokinase-mediated plasmin activation in silico and in vitro Biophys. J. 101 2011 1825 1834
30. V. Ellis, M.F. Scully, and V.V. Kakkar Plasminogen activation by single-chain urokinase in functional isolation. A kinetic study J. Biol. Chem. 262 1987 14998 15003
31. M.A. Lucas, and D.L. Straight P.A. McKee The effects of fibrinogen and its cleavage products on the kinetics of plasminogen activation by urokinase and subsequent plasmin activity J. Biol. Chem. 258 1983 12171 12177
32. H.R. Lijnen, and B. Van Hoef D. Collen The mechanism of plasminogen activation and fibrin dissolution by single chain urokinase-type plasminogen activator in a plasma milieu in vitro Blood 73 1989 1864 1872
33. C. Chen, and J. Cui P. Shen Modeling of the role of a Bax-activation switch in the mitochondrial apoptosis decision Biophys. J. 92 2007 4304 4315
34. J. Cui, and C. Chen P. Shen Two independent positive feedbacks and bistability in the Bcl-2 apoptotic switch PLoS ONE 3 2008 e1469
35. Reference deleted in proof.
36. J.E. Murphy-Ullrich, and M. Poczatek Activation of latent TGF-β by thrombospondin-1: mechanisms and physiology Cytokine Growth Factor Rev. 11 2000 59 69
37. S.M. Kutz, and J. Hordines P.J. Higgins TGF-β1-induced PAI-1 gene expression requires MEK activity and cell-to-substrate adhesion J. Cell Sci. 114 2001 3905 3914
38. M.V. Cubellis, T.C. Wun, and F. Blasi Receptor-mediated internalization and degradation of urokinase is caused by its specific inhibitor PAI-1 EMBO J. 9 1990 1079 1085
39. S. Thorsen, and M. Philips B. Astedt Kinetics of inhibition of tissue-type and urokinase-type plasminogen activator by plasminogen-activator inhibitor type 1 and type 2 Eur. J. Biochem. 175 1988 33 39
40. V. Ellis, M.F. Scully, and V.V. Kakkar Plasminogen activation initiated by single-chain urokinase-type plasminogen activator. Potentiation by U937 monocytes J. Biol. Chem. 264 1989 2185 2188
41. U. Christensen, and L. Sottrup-Jensen Mechanism of α2- macroglobulin-proteinase interactions. Studies with trypsin and plasmin Biochemistry 23 1984 6619 6626
42. P.K. Anonick, and J.K. Yoo S.L. Gonias Characterization of the antiplasmin activity of human thrombospondin-1 in solution Biochem. J. 289 1993 903 909
43. C. Chen, and J. Cui P. Shen Robustness analysis identifies the plausible model of the Bcl-2 apoptotic switch FEBS Lett. 581 2007 5143 5150
44. F. Wen, and S. Chang H. Yu Development of dual-compartment perfusion bioreactor for serial coculture of hepatocytes and stellate cells in poly(lactic-co-glycolic acid)-collagen scaffolds J. Biomed. Mater. Res. B Appl. Biomater. 87 2008 154 162
45. S.F. Abu-Absi, L.K. Hansen, and W.S. Hu Three-dimensional co-culture of hepatocytes and stellate cells Cytotechnology 45 2004 125 140
46. J.R. Pomerening, E.D. Sontag, and J.E. Ferrell Jr. Building a cell cycle oscillator: hysteresis and bistability in the activation of Cdc2 Nat. Cell Biol. 5 2003 346 351
47. J.G. Albeck, and J.M. Burke P.K. Sorger Quantitative analysis of pathways controlling extrinsic apoptosis in single cells Mol. Cell 30 2008 11 25
48. D. Collen, and G. Tytgat P. Wallén Metabolism of plasminogen in healthy subjects: effect of tranexamic acid J. Clin. Invest. 51 1972 1310 1318
49. A. Hertig, and J. Berrou E. Rondeau Type 1 plasminogen activator inhibitor deficiency aggravates the course of experimental glomerulonephritis through overactivation of transforming growth factor β FASEB J. 17 2003 1904 1906
50. W. Zhang, and L. Tucker-Kellogg H. Yu Cell-delivery therapeutics for liver regeneration Adv. Drug Deliv. Rev. 62 2010 814 826
51. S.B. Nicholas, and E. Aguiniga W.A. Hsueh Plasminogen activator inhibitor-1 deficiency retards diabetic nephropathy Kidney Int. 67 2005 1297 1307
52. D.M. Bissell, D. Roulot, and J. George Transforming growth factor β and the liver Hepatology 34 2001 859 867
53. S.L. Friedman, G. Yamasaki, and L. Wong Modulation of transforming growth factor β receptors of rat lipocytes during the hepatic wound healing response. Enhanced binding and reduced gene expression accompany cellular activation in culture and in vivo J. Biol. Chem. 269 1994 10551 10558
54. D. Roulot, and A.M. Sevcsik S. Marullo Role of transforming growth factor β type II receptor in hepatic fibrosis: studies of human chronic hepatitis C and experimental fibrosis in rats Hepatology 29 1999 1730 1738
55. P.K. Anonick, B. Wolf, and S.L. Gonias Regulation of plasmin, miniplasmin, and streptokinase-plasmin complex by α2-antiplasmin, α2-macroglobulin, and antithrombin III in the presence of heparin Thromb. Res. 59 1990 449 462
56. J. Travis, and G.S. Salvesen Human plasma proteinase inhibitors Annu. Rev. Biochem. 52 1983 655 709
57. T. Eissing, and H. Conzelmann P. Scheurich Bistability analyses of a caspase activation model for receptor-induced apoptosis J. Biol. Chem. 279 2004 36892 36897
58. E.Z. Bagci, and Y. Vodovotz I. Bahar Bistability in apoptosis: roles of bax, bcl-2, and mitochondrial permeability transition pores Biophys. J. 90 2006 1546 1559
59. M. Köhler, S. Sen, C. Miyashita, R. Hermes, G. Pindur, M. Heiden, G. Berg, S. Mörsdorf, G. Leipnitz, and M. Zeppezauer Half-life of single-chain urokinase-type plasminogen activator (scu-PA) and two-chain urokinase-type plasminogen activator (tcu-PA) in patients with acute myocardial infarction Thromb. Res. 62 1991 75 81
60. S. Legewie, N. Blüthgen, and H. Herzel Mathematical modeling identifies inhibitors of apoptosis as mediators of positive feedback and bistability PLOS Comput. Biol. 2 2006 e120
61. K.C. Robbins, and L. Summaria Human plasminogen and plasmin Methods Enzymol. 19 1970 184 199
62. K. Saito, and M. Nagashima A. Takada The concentration of tissue plasminogen activator and urokinase in plasma and tissues of patients with ovarian and uterine tumors Thromb. Res. 58 1990 355 366
63. L. Riccalton-Banks, and R. Bhandari K.M. Shakesheff A simple method for the simultaneous isolation of stellate cells and hepatocytes from rat liver tissue Mol. Cell. Biochem. 248 2003 97 102
64. S. Vogel, and R. Piantedosi W.S. Blaner An immortalized rat liver stellate cell line (HSC-T6): a new cell model for the study of retinoid metabolism in vitro J. Lipid Res. 41 2000 882 893
65. L.T. Couto, J.L. Donato, and G. de Nucci Analysis of five streptokinase formulations using the euglobulin lysis test and the plasminogen activation assay Braz. J. Med. Biol. Res. 37 2004 1889 1894
66. D. Seth, and P.J. Hogg P.S. Haber Direct effects of alcohol on hepatic fibrinolytic balance: implications for alcoholic liver disease J. Hepatol. 48 2008 614 627
67. R.W. Stephens, and J. Pöllänen A. Vaheri Activation of pro-urokinase and plasminogen on human sarcoma cells: a proteolytic system with surface-bound reactants J. Cell Biol. 108 1989 1987 1995